Assessing quantitative chimerism longitudinally: technical considerations, clinical applications and routine feasibility (Q36721963)

15 August 2017

1 reference

title

Assessing quantitative chimerism longitudinally: technical considerations, clinical applications and routine feasibility (English)

1 reference

15 August 2017

Kristt D

1

1 reference

15 August 2017

Stein J

series ordinal

2

1 reference

15 August 2017

Yaniv I

series ordinal

3

1 reference

15 August 2017

Klein T

series ordinal

4

1 reference

15 August 2017

language of work or name

English

0 references

publication date

29 January 2007

1 reference

Bone Marrow Transplantation

15 August 2017

published in

1 reference

15 August 2017

volume

39

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

255-268

1 reference

Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for testing in different clinical-biological situations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Monthly prospective analysis of hematopoietic chimerism after allogeneic hematopoietic cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Mixed hematopoietic chimerism at day 90 following allogenic myeloablative stem cell transplantation is a predictor of relapse and survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Sequential molecular monitoring of chimerism in chronic myeloid leukemia patients receiving donor lymphocyte transfusion for relapse after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Monitoring of lineage-specific chimaerism allows early prediction of response following donor lymphocyte infusions for relapsed chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Serial quantification of lymphoid and myeloid mixed chimerism using multiplex PCR amplification of short tandem repeat-markers predicts graft rejection and relapse, respectively, after allogeneic transplantation of CD34+ selected cells from peripher

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Diagnostic chimerism analysis after allogeneic stem cell transplantation: new methods and markers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

New energy transfer dyes for DNA sequencing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Assessing hematopoietic chimerism after allogeneic stem cell transplantation by multiplexed SNP genotyping using microarrays and quantitative analysis of SNP alleles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Highly sensitive patient-specific real-time PCR SNP assay for chimerism monitoring after allogeneic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Frankfurt experience.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Summary: reports on quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Quantitative analysis of chimerism after allogeneic bone marrow transplantation using immunomagnetic selection and fluorescent microsatellite PCR.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Geneva experience.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Vienna experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Paris-Robert Debré experience.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Tuebingen experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Reliability of quantitative chimerism results: assessment of sample performance using novel parameters.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Bl

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Molecular monitoring of T-cell chimerism early after allogeneic stem cell transplantation may predict the occurrence of acute GVHD grades II-IV.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

How and when should we monitor chimerism after allogeneic stem cell transplantation?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Full donor chimerism by day 30 after allogeneic peripheral blood progenitor cell transplantation is associated with a low risk of relapse in pediatric patients with hematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

NK cell recovery, chimerism, function, and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CD2 mAb, Medi-507.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Interactive ChimerTrack software facilitates computation, visual displays and long-term tracking of chimeric status based on STRs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705576

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705576

1 reference

15 August 2017

1 reference